REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$21.78
Tradestie Score
34
Market Cap
$328.62M
Analyst Upside
+7.1%
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$6.67
|
$2.34B | - | 42 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$87.08
|
$2.33B | - | 37 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$32.82
|
$2.33B | - | 44 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.59
|
$2.23B | - | 50 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$29.94
|
$2.22B | - | 40 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.04
|
$2.21B | - | 66 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$19.73
|
$2.18B | - | 49 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$13.65
|
$2.08B | - | 44 | Compare |
More REPL Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2836)
215 stocks in this industry